Discovery of a Novel Autophagy Activator to Treat Autosomal Dominant Tubulointerstitial Kidney Disease
Yeawon Kim(Washington University in St. Louis), Ying Maggie Chen, Bryce G. Johnson(Pfizer (United States)), Chuang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Eric Tycksen(Washington University in St. Louis), Chenjian Gu(Washington University in St. Louis), Anuradhika Puri(Washington University in St. Louis), Jothilingam Sivapackiam(Mallinckrodt (United States)), Terri Pietka(Washington University in St. Louis), Sun-Ji Park(Washington University in St. Louis), Maria Lindahl(University of Helsinki), Anthony J. Bleyer(Wake Forest University), Jeremy S. Duffield(Brigham and Women's Hospital), Stanislav Kmoch(Charles University), Meredith E. Jackrel(Washington University in St. Louis), Fumihiko Urano(Washington University in St. Louis), Vijay Sharma(Washington University in St. Louis), Kendrah Kidd(Wake Forest University)
Cited by 0
Related Papers
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
|American Journal Of Pathology|2009|1.4k
Targeting Endothelium-Pericyte Cross Talk by Inhibiting VEGF Receptor Signaling Attenuates Kidney Microvascular Rarefaction and Fibrosis
|American Journal Of Pathology|2011|263
Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation
|Human Molecular Genetics|2016|171